2nd Annual NASH Summit 2018 Boston, Massachusetts, USA 23-25 April 2018

Description:
As the industry's most comprehensive NASH forum, the NASH Summit returns with an unrivalled depth and breadth of cutting-edge NASH science from drug discovery through to late stage clinical development.

Across 3 parallel streams of learning, 48 expert speakers including Gilead, Allergan and Novartis will share advances in:

. Validating non-invasive biomarkers to confidently stratify patients and enhance clinical response
. Evaluating the scientific rationale behind combination therapy for more effective treatment
. Conclusively comparing in vitro and in vivo models to better recapitulate human NASH and confidently progress into the clinic

Join 150+ drug developers from 120+ organizations at this focused discussion and networking forum. Address this huge unmet clinical need and gain actionable insights to propel your candidate to therapeutic success.

URLs:
Brochure: https://go.evvnt.com/169819-1
Booking: https://go.evvnt.com/169819-2

Prices:
Conference Only: USD 2599,
Workshop Only: USD 699

Speakers: Jason Campagna (Intercept Pharmaceuticals), Philip Just Larsen (Sanofi), Jamie Bates (Gilead Sciences), Dean Hurn (Genfit), Edgar Charles (Bristol-Myers Squibb)

Time: 8:00 am to 6:00 pm